Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 27;15(9):15146-60.
doi: 10.3390/ijms150915146.

The three integrated phases of left atrial macrophysiology and their interactions

Affiliations
Review

The three integrated phases of left atrial macrophysiology and their interactions

Raman Mehrzad et al. Int J Mol Sci. .

Abstract

Our understanding of the left atrium is growing, although there are many aspects that are still poorly understood. The left atrium size as an imaging biomarker has been consistently shown to be a powerful predictor of outcomes and of different cardiovascular disorders, such as, but not limited to, atrial fibrillation, congestive heart failure, mitral regurgitation and stroke. Left atrial function has been conventionally divided into three integrated phases: reservoir, conduit and booster-pump. The highly dynamic left atrium and its response to the stretch and secretion of atrial neuropeptides leaves the left atrium far from being a simple transport chamber. The aim of this review is to provide an understanding of the left atrial physiology and its relation to disorders within the heart.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The three integrated phases of left atrium (LA) function in relation to the electrocardiogram (ECG).

References

    1. Garcia M.J. Left ventricular filling. Heart Fail. Clin. 2008;4:47–56. doi: 10.1016/j.hfc.2007.10.005. - DOI - PubMed
    1. Potter L.R., Yoder A.R., Flora D.R., Antos L.K., Dickey D.M. Natriuretic peptides: Their structures, receptors, physiologic functions and therapeutic applications. Handb. Exp. Pharmacol. 2009;191:341–366. doi: 10.1007/978-3-540-68964-5_15. - DOI - PMC - PubMed
    1. Serra J.L., Bendersky M. Atrial fibrillation and renin-angiotensin system. Ther. Adv. Cardiovasc. Dis. 2008;2:215–223. doi: 10.1177/1753944708092111. - DOI - PubMed
    1. Tsang T.S., Abhayaratna W.P., Barnes M.E., Miyasaka Y., Gersh B.J., Bailey K.R., Cha S.S., Seward J.B. Prediction of cardiovascular outcomes with left atrial size: Is volume superior to area or diameter? J. Am. Coll. Cardiol. 2006;47:1018–1023. doi: 10.1016/j.jacc.2005.08.077. - DOI - PubMed
    1. Laukkanen J.A., Kurl S., Eranen J., Huttunen M., Salonen J.T. Left atrium size and the risk of cardiovascular death in middle-aged men. Arch. Intern. Med. 2005;165:1788–1793. doi: 10.1001/archinte.165.15.1788. - DOI - PubMed

MeSH terms

LinkOut - more resources